Scientists reported that PALI1 was upregulated in advanced prostate cancer and competed with JARID2 for binding to the polycomb repressive complex 2 core subunit SUZ12.
[Molecular Cell]
PALI1 Promotes Tumor Growth through Competitive Recruitment of PRC2 to G9A-Target Chromatin for Dual Epigenetic Silencing
